Event: The 3rd Annual Biopharma Innovation Conference 2018

Dates: September 19 - 20, 2018

Venue: Wyndham Bund East Shanghai, China

Weblink: www.bioinnovationforum.com

Contact: Marketing Department

Tel: +86 21 3160 2153

Email: Marketing@wbfgroup.com

As the BioPharma industry grows in China & the Asian region. A part of our highly successful Biopharma series, the event, which attracts over 300 attendees, is the leading industry platform for Biopharma, biotech, Manufacturing Equipments, Bioscience and Analytical Equipments, Facility Design, Cold Chain, CMOs, CROs, Research institutes, investors, Technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China.

Covering topics ranging from latest regulations impacting to International partnering; from Biosimilar to CMO and Clinical development; from Protein engineering technology to Antibody development; from Biomanufacturing to Bioprocessing; from Upstream: Cell Culture and Cell Line Development to Downstream: Protein Purification, Expression & Characterization; from Cutting edge technology & solutions to best Practice case studies; from business strategy, investment to innovation.

This is probably the most important event in the year on biopharma in terms of participants. It cannot be missed.

With over 40 speakers and estimation to bring over 300 Biopharma professionals, the key congress topics will cover:

·         New investment and outlook in china biopharma industry, Biotech Innovation and regulatory compliance

·         Facility Innovations In design, technology and flexibility, Innovation in technologies and manufacturing process

·         Advancements on scale-up, production, purification, expression technologies, quality control

·         Discuss the advanced strategy and solutions to enhance biosimilars’ bioprocessing stability and reliability

·         Summarize the experience from clinical trials’ design, statistics, tests, indications and etc to quicken biosimilars’ clinical development

·         Examine advances in Innovation & Technology for Biosimilar Development, Overlook the market access and clinical accessibility for future biosimilars

·         Antibody & protein structure design and optimization, Leading protein and antibody engineering technology and innovational application

·         Functional and Analytical Characterization of Host Cell Lines, Analytical Methods and Formulation Strategies and Technologies

·         Innovative approaches and optimization in early cell line development and media

·         Following up the updated R&D progress of new structural antibody, and protein under different indications

On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Biopharma industry in Asia.